Showing results (1431-1440 of 1,615) with videos related to

Sort By:
Pageof 162
Journal for Immunotherapy of Cancer|April 21, 2023
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE studyRoberto Moretto, Daniele Rossini, Aurélie Catteau, et al.
Purinergic Signalling|July 4, 2012
Purinergic system ecto-enzymes participate in the thromboregulation of patients with indeterminate form of Chagas diseaseViviane do Carmo Gonçalves Souza, Karine B Schlemmer, Cristiano B Noal, et al.
Cells|May 13, 2023
New Insights into the Impact of Human Papillomavirus on Oral Cancer in Young Patients: Proteomic Approach Reveals a Novel Role for S100A8Marisol Miranda-Galvis, Carolina Carneiro Soares, Carolina Moretto Carnielli, et al.
European Journal of Cancer (Oxford, England : 1990)|April 30, 2025
The relative dose intensity of first-line FOLFOXIRI and FOLFOX/FOLFIRI both in combination with bevacizumab affects prognosis of metastatic colorectal cancer patients: A pooled analysis of TRIBE and TRIBE2 studiesR Moretto, D Rossini, Mariam Grazia Polito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2011
Phase I study of decitabine in combination with vorinostat in patients with advanced solid tumors and non-Hodgkin's lymphomasAnastasios Stathis, Sebastien J Hotte, Eric X Chen, et al.
Food Science & Nutrition|December 2, 2024
Omega-3 supplementation attenuates doxorubicin-induced cardiotoxicity but is not related to the ceramide pathwayMarina Gaiato Monte, Carolina Rodrigues Tonon, Anderson Seiji Fujimori, et al.
JCO Precision Oncology|November 7, 2024
KRASG12D-Mutated Metastatic Colorectal Cancer: Clinical, Molecular, Immunologic, and Prognostic Features of a New Emerging Targeted AlterationRoberto Moretto, Daniele Rossini, Sabina Murgioni, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2021
Exploring clinical and gene expression markers of benefit from FOLFOXIRI/bevacizumab in patients with BRAF-mutated metastatic colorectal cancer: Subgroup analyses of the TRIBE2 studyRoberto Moretto, Mirella Giordano, Anello M Poma, et al.
Bioorganic & Medicinal Chemistry|November 24, 2005
Bicyclic and tricyclic thiophenes as protein tyrosine phosphatase 1B inhibitorsA F Moretto, S J Kirincich, W X Xu, et al.
World Journal of Urology|November 10, 2025
Evolution of renal function after ureteroscopy in solitary kidneyCharles Jaouen, Olivier Traxer, Stefano Moretto, et al.
Pageof 162